Evidence map›Paper›PMID 35285877›Full record

ArticleAmerican journal of clinical pathology2022

Effects of Different Centrifugation Protocols on the Detection of EGFR Mutations in Plasma Cell-Free DNA.

Kyung-Hwa Shin, Sun Min Lee, Kongkyoung Park, Hyunji Choi, In-Suk Kim, Seong Hoon Yoon, Seung Hwan Oh

Open access · hybridAbstract read
In one paragraph

Article in American journal of clinical pathology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.7field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Kyung-Hwa ShinDepartment of Laboratory Medicine, Busan, South Korea.
Sun Min LeeDepartment of Laboratory Medicine, Pusan National University School of Medicine, Busan, South Korea.ORCID 0000-0002-2896-3365
Kongkyoung ParkDepartment of Laboratory Medicine, Yangsan, South Korea.
Hyunji ChoiDepartment of Laboratory Medicine, Yangsan, South Korea.
In-Suk KimDepartment of Laboratory Medicine, Pusan National University School of Medicine, Busan, South Korea.ORCID 0000-0002-7243-9173
Seong Hoon YoonLung Cancer Clinic, Pulmonary Medicine Center, Pusan National University Yangsan Hospital, Yangsan, South Korea.
Seung Hwan OhDepartment of Laboratory Medicine, Pusan National University School of Medicine, Busan, South Korea.
Donggwon Science and Technology University · KRPusan National University Hospital · KRPusan National University Yangsan Hospital · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesVarious preanalytical factors, including the collection tube, storage conditions, and centrifugation, affect the detection results of plasma cell-free DNA (cfDNA). We compared the effect of different centrifugation protocols on the detection of EGFR mutations in cfDNA.

methodsWe analyzed 117 plasma specimens from 110 patients with non-small cell lung cancer using the cobas EGFR Mutation Test v2 (Roche Diagnostics). We compared the identified EGFR mutations and semiquantitative index values from the 1- and 2-step centrifugation groups and confirmed the clinical impact of differences in the results after further high-speed centrifugation.

resultsWe detected EGFR mutations in 44 (37.6%) and 47 (40.2%) samples that were centrifuged once and twice, respectively; the 2 groups showed an 89.7% (105/117) concordance and a strong correlation in their semiquantitative index values (r = 0.929). Among the 12 inconsistent result pairs, 9 samples of 2-step centrifugation (75%) were consistent with the results of a recent tissue biopsy.

conclusionsAdditional high-speed centrifugation has been shown to increase the sensitivity of EGFR mutation detection in a commercial in vitro diagnostic real-time polymerase chain reaction device and is an optimal preanalytical factor for detecting low-allele frequency gene mutations using low concentrations of cfDNA.

Indexed as

Carcinoma, Non-Small-Cell LungCell-Free Nucleic AcidsLung NeoplasmsCentrifugationErbB ReceptorsHumansMutationReagent Kits, DiagnosticCell-Free Nucleic AcidsEGFR protein, humanErbB ReceptorsReagent Kits, DiagnosticCell-free DNACentrifugationEpidermal growth factor receptor mutationsLiquid biopsyNon-small cell lung cancerPreanalytical factors

Identifiers

PMID35285877
PMCPMC9350828
OpenAlexW4210610743

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.